ASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary Shares

SINGAPORE, Dec. 03, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has priced its previously announced underwritten public offering of 5,124,527 American Depositary Shares (ADSs) at a public offering price of $2.50 per ADS.